Recently, Wondfo Biotech announced the launch of a rapid detection solution for Nipah virus, supporting global efforts in emerging infectious disease control. Based on Wondfo’s established colloidal gold immunochromatographic assay platform, the test delivers results within 30 minutes and is suitable for on-site screening and emergency response scenarios. Nipah virus is a highly pathogenic zoonotic virus primarily transmitted by fruit bats. Infection can lead to severe respiratory illness and encephalitis, with a case fatality rate ranging from 40% to 75%. The World Health Organization (WHO) has listed it as a priority pathogen for research and development. Wondfo’s new diagnostic kit offers advantages such as ease of use, no requirement for complex equipment, and clear visual results—making it ideal for deployment in resource-limited settings. This launch not only demonstrates the technical capabilities of Chinese companies in diagnosing emerging infectious diseases but also provides critical support for global public health security. The product is currently undergoing international regulatory approvals and is expected to be deployed in Nipah-endemic regions such as Southeast Asia, offering a vital tool for early warning and outbreak containment.
近日，万孚生物宣布推出针对尼帕病毒（Nipah virus）的快速检测方案，助力全球新发传染病防控。该方案基于万孚成熟的胶体金免疫层析技术平台，可在30分钟内完成样本检测，适用于现场筛查和应急响应场景。尼帕病毒是一种高致病性人畜共患病毒，主要通过果蝠传播，感染后可引发严重呼吸道疾病和脑炎，病死率高达40%至75%。世界卫生组织（WHO）已将其列为优先研究病原体之一。万孚生物此次推出的检测产品具有操作简便、无需复杂设备、结果直观等优势，特别适合在资源有限地区部署使用。该方案的推出不仅体现了中国企业在新发突发传染病诊断领域的技术实力，也为全球公共卫生安全提供了有力支持。目前，该产品正积极申请相关国际认证，未来有望在东南亚等尼帕病毒流行区域投入使用，为早期预警和疫情控制提供关键工具。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/22503.html